亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

N-甲基哌嗪 CAS No.:109-01-3

 
 
單價(jià) 135.00 / KG對比
銷量 暫無
發(fā)貨 湖北武漢市付款后48小時(shí)內(nèi)
庫存 6000KG起訂1KG
品牌 南箭
過期 長期有效
更新 2015-03-06 15:56
 

湖北遠(yuǎn)藥業(yè)有限公司孝南分公司

企業(yè)會員第12年
資料未認(rèn)證
保證金未繳納
詳細(xì)說明
中文名稱:N-甲基哌嗪
中文別名:1-甲基哌嗪
外文名: N-methyl piperazine
分子式: C5H12N2
分子量: 100.16
CAS No.:109-01-3
EINECS號: 203-639-5
含量(Purity):99.9%
物化性質(zhì)
熔點(diǎn) -6 °C
沸點(diǎn) 138 °C(lit.)
密度 0.903(lit.)
蒸氣密度 3.5 (vs air)
折射率 n20/D1.466(lit.)
閃點(diǎn) 108 °F
儲存條件 Store under Nitrogen
水溶解性 soluble
敏感性 Hygroscopic
BRN 102724
化學(xué)性質(zhì) 無色液體。沸點(diǎn)138℃(140℃),相對密度0.903(20/4℃),折光率1.4378,閃點(diǎn)42℃,溶于水、**、乙醇,與水、甲醇等任意比互溶,在水溶液中呈弱堿性。
用途(Useage): 用于制取抗菌類藥物甲哌利福霉素、抗精神病藥三氟拉嗪及氧氟沙星等 ,主要用作氧氟沙星、氯氮平、西地那非、吐立抗、佐匹克隆等藥物的中間體,亦可用于農(nóng)藥、染料、塑料等行業(yè)。
舉報(bào)收藏 0評論 0
更多>本企業(yè)其它產(chǎn)品
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |